Timothy Phoenix

10PUBLICATIONS
122CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesEpigenetics (incl. genome methylation and epigenomics)Molecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 04, 2026
Murine modeling of IDH-mutant 1p/19q-codeleted oligodendroglioma reveals genotype specific phenotypes.

|Feb 11, 2026
Lactylation fuels nucleotide biosynthesis and facilitates deuterium metabolic imaging of tumor proliferation in preclinical models of H3K27M-mutant gliomas.

Georgios Batsios, Céline Taglang, Suresh Udutha

|Jan 14, 2026
Combined inhibition of FACT and BET disrupts transcription to suppress tumor growth in mouse models of diffuse midline glioma.

Holly Holliday, Aaminah Khan, Anahid Ehteda

|Sep 25, 2025
Preclinical Evaluation of the Efficacy of the Cyclin-Dependent Kinase Inhibitor Ribociclib in Combination with Letrozole against Patient-Derived Glioblastoma Cells.

Sidharth N Gadgil, Aniruddha S Karve, Gary A Gudelsky

|Nov 04, 2024
FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma.

Selin Jessa, Antonella De Cola, Bhavyaa Chandarana

|Jul 08, 2022
FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits.

Jessica W Tsai, Paloma Cejas, Dayle K Wang

Pageof 2

Frequent Collaborators

2 joint publications

Dayle Wang

2 joint publications

Maria Tsoli

2 joint publications

Kevin Zhou

2 joint publications

David T W Jones